Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology
- PMID: 8364009
- DOI: 10.1161/01.atv.13.9.1253
Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology
Abstract
Mild homocysteinemia occurs surprisingly often in patients with premature vascular disease. We studied the possible enzymatic sources of this mild hyperhomocysteinemia and the control of homocysteine levels in plasma by treatment of patients with the cofactors and cosubstrates of homocysteine catabolism. We assessed homocysteine metabolism in 131 patients who had premature disease in their coronary, peripheral, or cerebrovascular circulation by using a standard oral methionine-load test. Impaired homocysteine metabolism occurred in 28 patients. We assayed levels of the primary enzymes of homocysteine catabolism in cultured skin fibroblast extracts from 15 of these 28 patients. The patients' cystathionine beta-synthase levels (3.68 +/- 2.52 nmol/h per milligram of cell protein, mean +/- SD) were markedly depressed compared with those from 31 healthy adult control subjects (7.61 +/- 4.49, P < .001). The patients' levels of 5-methyltetrahydrofolate: homocysteine methyltransferase were normal. While betaine: homocysteine methyltransferase was not expressed in skin fibroblasts, 24-hour urinary betaine and N,N-dimethylglycine measurements were consistent with normal or enhanced remethylation of homocysteine by betaine: homocysteine methyltransferase in the 13 patients tested. When treated daily with choline and betaine, pyridoxine, or folic acid, there was a normalization of the postmethionine plasma homocysteine level in 16 of 19 patients. Our results indicate that mild homocysteinemia in premature vascular disease may be caused by either a folate deficiency or deficiencies in cystathionine beta-synthase activity. It does not necessarily involve deficiencies of either 5-methyltetrahydrofolate:homocysteine methyltransferase or betaine:homocysteine methyltransferase. Effective treatment regimens are also defined.
Similar articles
-
[Homocysteine metabolism].Yakugaku Zasshi. 2007 Oct;127(10):1579-92. doi: 10.1248/yakushi.127.1579. Yakugaku Zasshi. 2007. PMID: 17917419 Review. Japanese.
-
Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.Semin Vasc Med. 2005 May;5(2):77-86. doi: 10.1055/s-2005-872394. Semin Vasc Med. 2005. PMID: 16047261 Review.
-
Methionine metabolism in mammals. Distribution of homocysteine between competing pathways.J Biol Chem. 1984 Aug 10;259(15):9508-13. J Biol Chem. 1984. PMID: 6746658
-
Methionine metabolism in mammals. The methionine-sparing effect of cystine.J Biol Chem. 1988 Aug 25;263(24):11750-4. J Biol Chem. 1988. PMID: 3403552
-
Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease.Atherosclerosis. 1992 Nov;97(1):97-106. doi: 10.1016/0021-9150(92)90055-l. Atherosclerosis. 1992. PMID: 1445498
Cited by
-
To Study the Role of Serum Homocysteine Levels and Ocular Involvement in Retinal Vasculitis.Indian J Clin Biochem. 2022 Apr;37(2):212-217. doi: 10.1007/s12291-021-00976-z. Epub 2021 Apr 20. Indian J Clin Biochem. 2022. PMID: 35463114 Free PMC article.
-
Nicotinamide metabolism regulates glioblastoma stem cell maintenance.JCI Insight. 2017 May 18;2(10):e90019. doi: 10.1172/jci.insight.90019. eCollection 2017 May 18. JCI Insight. 2017. PMID: 28515364 Free PMC article.
-
Hyperhomocysteinemia: An emerging risk factor for cardiovascular disease.Indian J Clin Biochem. 2003 Jan;18(1):8-14. doi: 10.1007/BF02867659. Indian J Clin Biochem. 2003. PMID: 23105365 Free PMC article.
-
Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.Indian J Clin Biochem. 2000 Aug;15(Suppl 1):20-30. doi: 10.1007/BF02867541. Indian J Clin Biochem. 2000. PMID: 23105265 Free PMC article.
-
Lowering homocysteine and modifying nutritional status with folic acid and vitamin B(12) in Indian patients of vascular disease.J Clin Biochem Nutr. 2012 May;50(3):222-6. doi: 10.3164/jcbn.11-72. Epub 2012 Feb 10. J Clin Biochem Nutr. 2012. PMID: 22573925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous